Selection from HEOR Bibliography

IMS logo
Search criteria
Country: Czech
 
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries
Authors: Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi
Affiliations: IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK
Publications: 
Presented at ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24–28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA.
Document Types: , Poster
Countries: , Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019
Condition Year Language Analysis type
, Hematology, Oncology 2019 English , Public Health, Survey research
 
 
Patient and caregiver indirect costs after acute cardiovascular events in Europe.
Authors: Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5
Affiliations: 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium
Publications: 
ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Types: , Oral presentation
Countries: , Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84816?pdfid=58963
Condition Year Language Analysis type
, Cardiovascular disease, Health economics 2018 English , Burden of illness, Cost of illness
 
 
COMMONALITIES AND DIFFERENCES IN DATA COLLECTION ACROSS EUROPEAN SPONDYLOARTHRITIS REGISTRIES
Authors: M. L. Hetland* 1, M. Østergaard1, J. Askling2, C. Gabay3, D. Nordstrom4, O. FitzGerald5, M. Hernández Miguel6, M. Santos7 , Z. Rotar8, H. Mann9, F. Iannone10, M. J. Nissen3, E. Hauge1, J. Gomez-Reino11, F. Díaz-González12, M. Tomsic8, K. Pavelka9, F. O'Shea5, C. Sullivan5, M. van de Sande13, I. E. van der Horst-Bruinsma13, G. J. Macfarlane14, G. T. Jones14, B. Gudbjørnsson15, T. K. Kvien16 on behalf of EuroSpA Study Group
Affiliations: 1DANBIO, Glostrup, Denmark, 2ARTIS, Stockholm, Sweden, 3SCQM, Geneva, Switzerland, 4ROB-FIN, Helsinki, Finland, 5ASRI, Dublin, Ireland, 6BIOBADASER, Barcelona, Spain, 7reuma.pt, Almada, Portugal, 8biorx.si, Ljubljana, Slovenia, 9ATTRA, Prague, Czech Republic, 10GISEA, Bari, Italy, 11BIOBADASER, Santiago, 12BIOBADASER, Santa Cruz de Tenerife, Spain, 13ARC, Amsterdam, Netherlands, 14BSRBR-AS, Aberdeen, United Kingdom, 15ICEBIO, Reykjavik, Iceland, 16NORDMARD, Oslo, Norway
Publications: 
EULAR, Madrid, 2017
Document Types: , Abstract
Countries: , Czech, Denmark, Finland, Ireland, Italy, Norway, Slovenia, Spain, Sweden, Switzerland
Abstract: http://ard.bmj.com/content/76/Suppl_2/656.3
Condition Year Language Analysis type
, Rheumatology 2017 English , Epidemiological study
 
 
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
Authors: Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1.
Affiliations: 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden.
Publications: 
Clinical Epidemiology
Document Types: , Article
Countries: , Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/
Condition Year Language Analysis type
, Oncology 2016 English , Literature Review
 
 
Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe.
Authors: Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3
Affiliations: 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium
Publications: 
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Types: , Abstract
Countries: , Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK
Condition Year Language Analysis type
, Cardiovascular disease 2016 English
 
 
Survey on appropriateness of use of nimesulide in nine European countries
Authors: Franchi S1, Heiman F2, Visentin E2, Sacerdote P1.
Affiliations: 1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. 2Cegedim Strategic Data Medical Research Srl, Milan, Italy.
Publications: 
Drug, Healthcare and Patient Safety 2015:7 51-55
Document Types: , Article
Countries: , Bulgaria, Czech, Greece, Hungary, Italy, Poland, Portugal, Romania, Slovakia
Condition Year Language Analysis type
, Pain 2015 English , Survey research
 
 
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Czech Republic
Authors: Troelsgaard A1, Pitcher A2, Veselá Š3, Lovato E2, Hemels M1
Affiliations: Janssen A/S, Birkerød, Denmark, 2IMS Health, London, UK, 3Janssen-Cilag Czech Republic, Prague, Czech Republic
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Czech
Condition Year Language Analysis type
, Diabetes 2014 English , Economic evaluation
 
 
Long-term clinical and cost outcomes of treatment with insulin detemir plus insulin aspart in type 1 diabetes patients in the Czech setting; data from the predictive study
Authors: 1Clegg JP, 1Valentine WJ, 2Rychna K, 3Honka M, 4Doležal T
Affiliations: 1IMS, Allschwil, Switzerland, 2Novo Nordisk s.r.o, Praha 6, Czech Republic, 3Faculty Hospital Ostrava, Ostrava, Czech Republic, 4Charles University in Prague, Prague 10, Czech Republic
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Czech
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Copyright 2023 IMS Health Incorporated. All rights reserved.